AstraZeneca’s mAb Saphnelo scores FDA Approval for the treatment of Lupus
Systemic lupus erythematosus (SLE) is the most common type of Lupus, which is an autoimmune disease. Autoimmune disorders are not so rare, which are characterized by the immune system attacking own body tissues, affecting the vital organs. SLE can affect brain, lungs and kidneys along with joints, skin and blood vessels. The Lupus Foundation of…
News Views